Immunology. How frustration leads to inflammation

Our plain-English summary of Immunology. How frustration leads to inflammation, by L.A. O'Neill (Science, 2008).

The study

• Author: L.A. O'Neill
• Journal: Science
• Published: 2008;320(5876):619-20
• Type of article: Comment
• Cited by: 42 articles, as counted by NIH iCite
• Read it: PubMed · Publisher

Summary of the article

This Perspective commented on a study by Dostert et al., published in the same issue, on how inhaled particles such as asbestos and silica lead to inflammation and lung disease. The author first outlined background on inflammation. Cellular receptors such as Toll-like and NOD-like receptors recognize harmful agents. Inflammasomes are multiprotein complexes containing caspase-1, which processes prointerleukin-1β into its mature form. Nalp3 is one inflammasome component, and it was already known to sense monosodium urate, the cause of gout. The author then summarized the findings of Dostert et al. Reducing Nalp3 expression in macrophages attenuated asbestos-induced caspase-1 activation and interleukin-1β secretion. Asbestos triggered potassium efflux. Asbestos fibres underwent 'frustrated' phagocytosis, and disrupting actin filaments with cytochalasin D inhibited interleukin-1β secretion. Inhibitors of reactive oxygen species and of NADPH oxidase reduced interleukin-1β production, while reducing thioredoxin increased it. Mice exposed to airborne chrysotile asbestos showed increased cell numbers in bronchoalveolar lavage fluid. Nalp3-deficient mice recruited fewer cells, had impaired cytokine production and were resistant to asbestos-induced lung injury. The author noted that how reactive oxygen species affect Nalp3 activation was unknown. He concluded that the study highlighted the importance of testing the interleukin-1 receptor antagonist anakinra as a treatment to slow the progression of asbestosis and silicosis. He added that Nalp3 itself might be a drug target.

PubMed has no abstract for this study, and the article doesn't print one. We wrote this summary from the full article with the help of AI. It is not the authors' wording.

In plain English

This article was a short commentary (a 'Perspective') by one author on a separate laboratory study by Dostert and colleagues, published in the same issue of Science. It reported no new research of its own. As the author described it, that study examined how asbestos and silica trigger inflammation. In macrophages (immune cells) exposed to asbestos, reducing a protein called Nalp3 lowered the release of the inflammatory signal interleukin-1β. Blocking actin filaments or blocking reactive oxygen species also reduced this response. Mice breathing air containing chrysotile asbestos showed signs of lung inflammation. Mice lacking Nalp3 recruited fewer cells to the lungs and were resistant to asbestos-induced lung injury. The author explained the findings through 'frustrated' phagocytosis: asbestos fibers are too large for macrophages to swallow. The author also noted that how reactive oxygen species affect Nalp3 is unknown. The author suggested that Nalp3 might prove to be a drug target for asbestosis and silicosis.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: Commentary (Perspective) describing another group's laboratory and animal study (Dostert et al., Science 2008); not original research
• Who was studied: In the study discussed: macrophages (immune cells) in the laboratory, plus normal mice and Nalp3-deficient mice; numbers not given in this commentary
• Exposure: Asbestos in macrophage experiments (amounts described only as physiologically relevant); chrysotile asbestos in air for the mouse experiments; silica is also discussed
• Main results:
  • In macrophages exposed to asbestos, reducing Nalp3 weakened caspase-1 activation and the release of interleukin-1β
  • Disrupting actin filaments with cytochalasin D inhibited the effect of asbestos (and monosodium urate) on interleukin-1β release
  • Blocking NADPH oxidase with a drug, or reducing its p22phox subunit, reduced interleukin-1β release in response to asbestos
  • Nalp3-deficient mice were resistant to asbestos-induced lung injury
  • In the author's explanatory figure, asbestos crystals are too large for macrophages to engulf, leading to 'frustrated' phagocytosis
• The authors' conclusion: The author suggested that Nalp3 might be a drug target for asbestosis and silicosis
• Limitations the authors state:
  • The author stated that it is unknown how reactive oxygen species affect Nalp3 activation

Topics

Medical terms in this study, explained in our Lexicon: Inflammation, Macrophage, Phagocytosis, Reactive Oxygen Species (ROS), Chrysotile, Bronchoalveolar Lavage (BAL), Cytokine, Silicosis.

Related studies

• Stromelysin-2 (MMP-10) facilitates clearance and moderates inflammation and cell death following lung exposure to long multiwalled carbon nanotubes — T.C. Vandivort, T.P. Birkland, et al. (2017)
• Inflammation and cancer — M. Murata (2018)
• Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura — F.A. Murphy, C.A. Poland, et al. (2011)
• Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation — H. Yang, Z. Rivera, et al. (2010)
• The selective release of lysosomal acid hydrolases from mouse peritoneal macrophages by stimuli of chronic inflammation — H.U. Schorlemmer, P. Davies, et al. (1977)
• A dual role for the immune response in a mouse model of inflammation-associated lung cancer — M. Dougan, D. Li, et al. (2011)

Browse more research in Science, or return to medical research.